Suppr超能文献

癫痫大鼠中的叶酸稳态

Folate homeostasis in epileptic rats.

作者信息

Mann Aniv, Portnoy Emma, Han Hadas, Inbar Dorrit, Blatch Dana, Shmuel Miriam, Ben-Hur Tamir, Eyal Sara, Ekstein Dana

机构信息

Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, 91120 Israel.

Department of Neurology, Agnes Ginges Center for Human Neurogenetics, Hadassah Hebrew University Medical Center, Jerusalem, 91120, Israel.

出版信息

Epilepsy Res. 2018 May;142:64-72. doi: 10.1016/j.eplepsyres.2018.03.014. Epub 2018 Mar 16.

Abstract

Folate is involved in metabolic processes and it has been implicated in both aggravation and amelioration of seizures. The aim of the current work was to study the effect of chronic temporal lobe epilepsy (TLE) on the plasma and brain concentrations of folate and on its uptake carriers in the brain - the reduced folate carrier (RFC), folate receptor α (FRα) and proton coupled folate transporter (PCFT). We utilized the rat lithium pilocarpine model for TLE. Approximately two months following status epilepticus, rats with spontaneous recurrent seizures (SRS) were sacrificed for brain and plasma folate concentration analyses and folate uptake carrier expression studies. RT-PCR and western blot analyses were utilized for quantification of folate carriers' mRNAs and proteins, respectively. The distribution of folate carriers in the brain was studied using immunohistochemistry. In the SRS rats we found lower plasma concentrations (10 ± 0.9 in control vs. 6.6 ± 1.6 ng/ml in SRS, P < 0.05), but preserved cortical and increased hippocampal levels of folate (0.5 ± 0.1 in control vs. 0.9 ± 0.2 ng/mg in SRS, P = 0.055). Hippocampus - to - plasma ratio of folate concentration was 3-fold higher in the SRS group, compared with the controls (0.13 ± 0.03 vs. 0.04 ± 0.02, respectively; P < 0.01). mRNA and protein levels of the folate uptake carriers did not differ between SRS rats and controls. However, immunofluorescent staining quantification revealed that the emission intensity of both RFC and FRα was elevated 8-fold and 4-fold, respectively, in hippocampal CA1 neurons of SRS rats, compared to controls (P < 0.01). PCFT was unquantifiable. If corroborated by complementary research in humans, the findings of this study may be utilized clinically for supplemental therapy planning, in imaging the epileptic focus, and for drug delivery into the epileptic brain. Further studies are required for better elucidating the clinical and mechanistic significance of altered folate balances in the epileptic brain.

摘要

叶酸参与代谢过程,与癫痫发作的加重和缓解均有关联。本研究的目的是探讨慢性颞叶癫痫(TLE)对血浆和脑内叶酸浓度及其脑内摄取载体——还原型叶酸载体(RFC)、叶酸受体α(FRα)和质子偶联叶酸转运体(PCFT)的影响。我们采用大鼠匹罗卡品锂模型诱导TLE。癫痫持续状态后约两个月,处死出现自发性反复癫痫发作(SRS)的大鼠,进行脑和血浆叶酸浓度分析以及叶酸摄取载体表达研究。分别利用逆转录聚合酶链反应(RT-PCR)和蛋白质免疫印迹法对叶酸载体的mRNA和蛋白质进行定量分析。采用免疫组织化学方法研究叶酸载体在脑内的分布。在SRS大鼠中,我们发现其血浆浓度较低(对照组为10±0.9,SRS组为6.6±1.6 ng/ml,P<0.05),但皮质叶酸水平保持不变,海马叶酸水平升高(对照组为0.5±0.1,SRS组为0.9±0.2 ng/mg,P=0.055)。与对照组相比,SRS组海马与血浆的叶酸浓度比值高出3倍(分别为0.13±0.03和0.04±0.02;P<0.01)。SRS大鼠和对照组之间叶酸摄取载体的mRNA和蛋白质水平没有差异。然而,免疫荧光染色定量分析显示,与对照组相比,SRS大鼠海马CA1神经元中RFC和FRα的发射强度分别升高了8倍和4倍(P<0.01)。PCFT无法定量。如果本研究结果得到人体补充研究的证实,那么本研究结果可在临床上用于辅助治疗方案的制定、癫痫病灶的成像以及向癫痫脑内给药。需要进一步研究以更好地阐明癫痫脑内叶酸平衡改变的临床和机制意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验